MYnd Analytics to Provide TeleEAP Services for Integrated Behavioral Health, a National Managed Behavioral Health Company


MISSION VIEJO, Calif., Sept. 20, 2018 (GLOBE NEWSWIRE) -- MYnd Analytics, Inc. (NASDAQ: MYND), a market leader in improving the delivery of mental health through the combination of telemedicine and data analytics/augmented intelligence, today announced that its wholly owned subsidiary, Arcadian Telepsychiatry Services LLC, has partnered with Integrated Behavioral Health, Inc. (“IBH”), a pioneer in managed behavioral health and integrated employee assistance programs and services, to provide TeleEAP services to IBH’s members. IBH currently serves over 7 million members, representing 26,000 individual clients across the United States and is headquartered in Costa Mesa, California.

Ed Bosanac, Dr.P.H., Chief Executive Officer, stated “IBH is thrilled by the partnership with Arcadian and the opportunity to the improve access for our members through MYnd’s TeleEAP network.”

Robert Plotkin, CEO and Founder of Arcadian, stated, “This partnership is another example of the growing demand for telepsychiatry services and the scalability of our platform. Although it may take several quarters to ramp up our services across their network, we look forward to supporting IBH’s 7 million members and providing their customers with TeleEAP services in order to achieve their goal of having healthy, safe, and productive employees and members.”

About Integrated Behavioral Health, Inc.

IBH is a pioneer in managed behavioral health and integrated employee assistance programs and services. As a boutique managed care company with a national footprint, IBH partners with employers and health plans to provide clients personalized and customized behavioral health plans with high-quality clinical care, uncompromising service to patients, providers and clients with outcomes driven, cost-effective care plans. Along with its subsidiaries Reliant Behavioral Health ("RBH"), Quality Health Solutions ("QHS"), American Behavioral Health Benefit Managers ("ABBM") and CFR EAP Preferred ("CFR"), IBH has successfully managed treatment and benefits for self‐insured employers, medical and disability carriers, and health plans for over 30 years. IBH currently serves over 7 Million members, representing 26,000 individual clients across the United States. IBH strives to achieve and maintain a healthy, safe and productive pool of employees and members for employers and health plans. For more information, please visit www.ibhcorp.com.

About MYnd Analytics

MYnd Analytics, Inc. (www.myndanalytics.com) is a predictive analytics company that has developed a decision support tool to help physicians reduce trial and error treatment in mental health and provide more personalized care to patients. The Company’s Psychiatric EEG Evaluation Registry, or PEER Online, is a registry and reporting platform that allows medical professionals to exchange treatment outcome data for patients referenced to objective neurophysiology data obtained through a standard electroencephalogram (EEG). Based on the Company’s original physician-developed database, there are now more than 40,000 outcomes for over 11,000 unique patients in the PEER registry. The goal of PEER Online is to provide objective, personalized data to assist physicians in the selection of appropriate medications. To read more about the benefits of this patented technology for patients, physicians and payers, please visit: www.myndanalytics.com.

MYnd also operates its wholly owned subsidiarity Arcadian Telepsychiatry Services, LLC which manages a suite of services including telepsychiatry, teletherapy, digital patient screening, curbside consultation, on-demand services, and scheduled encounters for all age groups. Arcadian utilizes patient engagement and re-engagement strategies so that care is effectively completed, helping to comfortably move inpatient care to outpatient, assisting patients in readjusting to their life routine, as well as reducing wait times for mental health treatment. Arcadian’s customer base includes major health plans, health systems, and community-based organizations.

Forward-looking Statements

Except for the historical information contained herein, the matters discussed are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, as amended. These forward-looking statements involve risks and uncertainties, such as statements regarding market developments, new products and growth strategies, Arcadian's ability to reduce patient suffering through increased access to care, Arcadian's ability to use MYnd’s data analytics capabilities to successfully reduce trial and error prescribing, advantages offered by telemedicine, the ability of MYnd’s and Arcadian's products to successfully target objectivity and increased efficiency in the treatment of depression and other mental health and psychiatric illnesses, as well as those risks and uncertainties set forth in MYnd's filings with the Securities and Exchange Commission. These risks and uncertainties could cause actual results to differ materially from any forward-looking statements made herein.

Contact:

Crescendo Communications, LLC
Tel: +1 (212) 671-1020
Email: mynd@crescendo-ir.com